Public Event Detail
Atlas Capital Advisors Inc. Makes New Investment in Johnson & Johnson $JNJ
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Historical observations only. No forecasts, recommendations, buy/sell ratings, or portfolio advice.
2026-06-15JPMJPMorgan ChaseAlpha Vantage Newsearnings
Event summary
Atlas Capital Advisors Inc. has made a new investment in Johnson & Johnson, purchasing 5,769 shares valued at approximately $1.19 million in the fourth quarter. This comes as Johnson & Johnson reported strong Q1 results, beating EPS and revenue estimates, and raised its quarterly dividend. The stock maintains a "Moderate Buy" consensus among analysts with an average price target of $253.04.
Attached public signals
Observed outcomes
7d returnPending
30d returnPending
90d returnPending
Relative 90d returnPending